Shambhavi Kumar

Shambhavi supports clients with data-driven analyses by processing large datasets consisting of medical and pharmacy claims to generate evidence using real-world data.

She has research experience in providing data analytics support for health economics studies, projects on comparative effectiveness, outcomes research, and predictive modeling by using SAS, SQL, and statistical analysis.

Shambhavi has a diverse background in data science and analytics, having contributed to data-driven projects across industries. Prior to joining Avalere, she was a business intelligence analyst at a telehealth start-up, analyzing patient-generated biometric data and claims data to measure health outcomes.

Shambhavi holds an MS in Information Systems with a focus on data analytics from University of Maryland, College Park, and a BE in electronics and telecommunication from the University of Pune.

Authored Content

The COVID-19 pandemic has brought renewed attention and urgency to mitigating access barriers to recommended vaccines.

Avalere analysis finds Medicare incurred $106.4 billion in 2016–2018 treating diseases potentially preventable with inline vaccines and select pipeline vaccine candidates. Those diseases also resulted in beneficiary costs of approximately $9.6 billion during the same time period.